BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38373870)

  • 1. Pan-European survey on current treatment strategies in patients with upfront resectable colorectal liver metastases.
    Kuiper BI; Abu Hilal M; Aldrighetti LA; Björnsson B; D'Hondt M; Dopazo C; Fretland ÅA; Isoniemi H; Philip Jonas J; Kazemier G; Lesurtel M; Primrose J; Schnitzbauer AA; Buffart T; Gruenberger B; Swijnenburg RJ; Gruenberger T
    HPB (Oxford); 2024 May; 26(5):639-647. PubMed ID: 38373870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating agreement regarding the resectability of colorectal liver metastases: a national case-based survey of hepatic surgeons.
    Mohammad WM; Martel G; Mimeault R; Fairfull-Smith RJ; Auer RC; Balaa FK
    HPB (Oxford); 2012 May; 14(5):291-7. PubMed ID: 22487066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing resectability of colorectal liver metastases: How do different subspecialties interpret the same data?
    Aubin JM; Bressan AK; Grondin SC; Dixon E; MacLean AR; Gregg S; Tang P; Kaplan GG; Martel G; Ball CG
    Can J Surg; 2018 Aug; 61(4):251-256. PubMed ID: 30067183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Liver Metastases from Colorectal Cancer: a Multicenter, Propensity Score-Matched Cohort Study.
    Hirokawa F; Ueno M; Nakai T; Kaibori M; Nomi T; Iida H; Tanaka S; Komeda K; Hayami S; Kosaka H; Hokuto D; Kubo S; Uchiyama K
    J Gastrointest Surg; 2022 Apr; 26(4):772-781. PubMed ID: 34664190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatic metastasis of colorectal cancer--current therapeutic possibilities].
    Popescu I; Alexandrescu S
    Chirurgia (Bucur); 2010; 105(2):155-69. PubMed ID: 20540227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of upfront hepatectomy without neoadjuvant chemotherapy for resectable colorectal liver metastasis.
    Ono K; Abe T; Oshita A; Sumi Y; Yano T; Okuda H; Kurayoshi M; Kobayashi T; Ohdan H; Noriyuki T; Nakahara M
    World J Surg Oncol; 2021 Apr; 19(1):97. PubMed ID: 33820549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is neoadjuvant chemotherapy appropriate for patients with resectable liver metastases from colorectal cancer?
    Hirokawa F; Asakuma M; Komeda K; Shimizu T; Inoue Y; Kagota S; Tomioka A; Uchiyama K
    Surg Today; 2019 Jan; 49(1):82-89. PubMed ID: 30255329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Resectability Assessment of the Dutch Colorectal Cancer Group Liver Metastases Expert Panel.
    Huiskens J; Bolhuis K; Engelbrecht MR; De Jong KP; Kazemier G; Liem MS; Verhoef C; de Wilt JH; Punt CJ; van Gulik TM;
    J Am Coll Surg; 2019 Dec; 229(6):523-532.e2. PubMed ID: 31520695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAF V600E potentially determines "Oncological Resectability" for "Technically Resectable" colorectal liver metastases.
    Kobayashi S; Takahashi S; Nomura S; Kojima M; Kudo M; Sugimoto M; Konishi M; Gotohda N; Taniguchi H; Yoshino T
    Cancer Med; 2021 Oct; 10(20):6998-7011. PubMed ID: 34535965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of tumour biological factors in technical anatomical resectability assessment of colorectal liver metastases following induction systemic treatment: An analysis of the Dutch CAIRO5 trial.
    Bolhuis K; Bond MJG; Van Amerongen MJ; Komurcu A; Chapelle T; Dejong CHC; Engelbrecht MRW; Gerhards MF; Grünhagen DJ; van Gulik TM; Hermans JJ; De Jong KP; Kazemier G; Klaase JM; Kok NFM; Leclercq WKG; Liem MSL; van Lienden KP; Molenaar IQ; Neumann UP; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; May AM; Punt CJA; Swijnenburg RJ;
    Eur J Cancer; 2023 Apr; 183():49-59. PubMed ID: 36801606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R1 Resection for Colorectal Liver Metastases: a Survey Questioning Surgeons about Its Incidence, Clinical Impact, and Management.
    Viganò L; Costa G; Cimino MM; Procopio F; Donadon M; Del Fabbro D; Belghiti J; Kokudo N; Makuuchi M; Vauthey JN; Torzilli G
    J Gastrointest Surg; 2018 Oct; 22(10):1752-1763. PubMed ID: 29948554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases: Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group.
    Bond MJG; Kuiper BI; Bolhuis K; Komurcu A; van Amerongen MJ; Chapelle T; Dejong CHC; Engelbrecht MRW; Gerhards MF; Grünhagen DJ; van Gulik T; Hermans JJ; de Jong KP; Klaase JM; Kok NFM; Leclercq WKG; Liem MSL; van Lienden KP; Molenaar IQ; Neumann UP; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; Kazemier G; May AM; Punt CJA; Swijnenburg RJ
    Ann Surg Oncol; 2023 Sep; 30(9):5376-5385. PubMed ID: 37118612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements.
    Abdalla EK; Bauer TW; Chun YS; D'Angelica M; Kooby DA; Jarnagin WR
    HPB (Oxford); 2013 Feb; 15(2):119-30. PubMed ID: 23297723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of neoadjuvant chemotherapy in patients with high-risk resectable colorectal liver metastases.
    Ninomiya M; Emi Y; Motomura T; Tomino T; Iguchi T; Kayashima H; Harada N; Uchiyama H; Nishizaki T; Higashi H; Kuwano H
    Int J Clin Oncol; 2021 Dec; 26(12):2255-2264. PubMed ID: 34519930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Borderline resectable for colorectal liver metastases: Present status and future perspective.
    Kitano Y; Hayashi H; Matsumoto T; Kinoshita S; Sato H; Shiraishi Y; Nakao Y; Kaida T; Imai K; Yamashita YI; Baba H
    World J Gastrointest Surg; 2021 Aug; 13(8):756-763. PubMed ID: 34512899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidisciplinary treatment of colorectal liver metastases.
    Schiergens TS; von Einem J; Thomas MN; Albertsmeier M; Giessen-Jung C; Dörsch M; Heiliger C; Drefs M; Andrassy J; Modest DP; Stintzing S; Guba M; Angele M; Werner J; Rentsch M
    Minerva Med; 2017 Dec; 108(6):527-546. PubMed ID: 28889727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastases.
    Khoo E; O'Neill S; Brown E; Wigmore SJ; Harrison EM
    HPB (Oxford); 2016 Jun; 18(6):485-93. PubMed ID: 27317952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the management of hepatic colorectal cancer metastases: is treatment consistent in Ontario?
    Sandhu L; Fox A; Nhan C; Barnett H; McLeod RS; Gallinger S; Moulton CA
    HPB (Oxford); 2012 Jun; 14(6):409-13. PubMed ID: 22568418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to convert to resectability the initially unresectable colorectal liver metastases.
    Popescu I; Alexandrescu S; Croitoru A; Boros M
    Hepatogastroenterology; 2009; 56(91-92):739-44. PubMed ID: 19621694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical Resection Preferences and Perceptions among Medical Oncologists Treating Liver Metastases from Colorectal Cancer.
    Choti MA; Thomas M; Wong SL; Eaddy M; Pawlik TM; Hirose K; Weiss MJ; Kish J; Green MR
    Ann Surg Oncol; 2016 Feb; 23(2):375-81. PubMed ID: 26561404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.